Leerink raised the firm’s price target on Doximity (DOCS) to $60 from $35 and keeps a Market Perform rating on the shares. The company’s Q2 earnings came in well above the firm’s and Wall Street’s expectations, with strength in results across the board, the analyst tells investors in a research note. The firm noted that the totality of the quarterly results also put the company’s incremental margin capture on display, as the EBITDA dropdown on the revenue beat was “quite significant.” Leerink added that it raised its price target to account for increased estimates and a “more robust” multiple on growth upside.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOCS:
- Doximity rises 36.5%
- Doximity rises 33.7%
- Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
- Doximity upgraded to Equal Weight at Wells Fargo after Q2 beat
- Doximity upgraded to Equal Weight from Underweight at Wells Fargo
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
